ESSA Pharma Inc.
Solid forms of an n-terminal domain androgen receptor inhibitor and uses thereof
Last updated:
Abstract:
The present invention relates to a crystalline form of Compound I, a salt, a solvate, or a solvate salt thereof or an amorphous form of Compound I, a salt, a solvate, or a solvate salt thereof. The present invention also provides compositions comprising the crystalline form and/or the amorphous form, therapeutic uses of the crystalline forms and/or the amorphous forms, and the compositions thereof.
Status:
Grant
Type:
Utility
Filling date:
9 Jun 2021
Issue date:
8 Feb 2022